CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive – Medscape
Medscape |
CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive
Medscape ATLANTA — New longer-term clinical data with chimeric antigen receptor (CAR) T cells now reported for patients with refractory and relapsed non-Hodgkin's lymphoma show that the responses are durable in about half of those treated, with the suggestion … New trials show cancer immunotherapy can be incredibly effective—and incredibly dangerous CAR T-cell therapies drive outcomes in lymphoma, myeloma CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients |
